Dashboard
1
The company has declared Negative results for the last 3 consecutive quarters
- ROCE(HY) Lowest at 6.49%
- INTEREST COVERAGE RATIO(Q) Lowest at 6,052.12
- RAW MATERIAL COST(Y) Grown by 10.36% (YoY)
2
With ROE of 0.66%, it has a Expensive valuation with a 2.43 Price to Book Value
3
Below par performance in long term as well as near term
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-16.22%
0%
-16.22%
6 Months
-17.99%
0%
-17.99%
1 Year
1.31%
0%
1.31%
2 Years
-34.04%
0%
-34.04%
3 Years
-42.8%
0%
-42.8%
4 Years
-59.21%
0%
-59.21%
5 Years
-62.01%
0%
-62.01%
LifeTech Scientific Corp. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
31.33%
EBIT Growth (5y)
33.67%
EBIT to Interest (avg)
28.17
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.34
Sales to Capital Employed (avg)
0.09
Tax Ratio
23.26%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
49.69%
ROE (avg)
8.76%
Valuation key factors
Factor
Value
P/E Ratio
370
Industry P/E
Price to Book Value
2.43
EV to EBIT
148.44
EV to EBITDA
128.39
EV to Capital Employed
3.16
EV to Sales
26.64
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
2.13%
ROE (Latest)
0.66%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
No Trend
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Dec'13 - YoY
Dec'13
Dec'12
Change(%)
Net Sales
89.80
60.20
49.17%
Operating Profit (PBDIT) excl Other Income
8.30
9.30
-10.75%
Interest
3.60
0.00
Exceptional Items
-21.00
0.00
Consolidate Net Profit
-13.90
1.80
-872.22%
Operating Profit Margin (Excl OI)
69.30%
106.80%
-3.75%
USD in Million.
Net Sales
YoY Growth in quarter ended Dec 2013 is 49.17% vs 25.42% in Dec 2012
Consolidated Net Profit
YoY Growth in quarter ended Dec 2013 is -872.22% vs 400.00% in Dec 2012
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
1,413.50
1,400.20
0.95%
Operating Profit (PBDIT) excl Other Income
271.20
389.50
-30.37%
Interest
2.00
0.80
150.00%
Exceptional Items
-29.80
-201.50
85.21%
Consolidate Net Profit
182.70
118.80
53.79%
Operating Profit Margin (Excl OI)
131.40%
224.10%
-9.27%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is 0.95% vs 9.73% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is 53.79% vs -67.95% in Dec 2023
About LifeTech Scientific Corp. 
LifeTech Scientific Corp.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






